OPKO traded down in preMarket, and the first 10 minutes of trading,
but has been up as much as 2.94% at its intraday H and is still up 2.16% <g>
Volume is now above 3,017,200 almost half its ADV.<g>
And the stock is again trading above the $11 level.<g>
There are several reasons to be optimistic about OPKO,
besides Dr, P.Frost persistent buying, among them:
The 4Kscore test seems to have good potential.<g>
And Tesaro should now start paying royalties to OPKO on the sales of Varubi, which is now available in ths U.S. <g>
finance.yahoo.com
Also OPKO expects to have approval for Rayaldee next year. And they expect to hear good news on the trial for the long acting Growth Hormone that PFE is conducting.<g>
When they reported the 3rdQ results,the Revenue increased to $143Ms from $20Ms, and net income was $128.2 Ms vs. a loss of $48.7Ms.<g>
And Dr. P.Frost said that besides the long acting drug for Hemophilia on which they are already working, they will be starting early next year on the long acting version of Oxyntomodulin for weight loss and type 2 diabetes.
That was the closing statement by Dr.Frost on the c.c., and for those that were not able to listen to it, this is a link to it and his comments at the end. <g>
finance.yahoo.com
Also as mentioned by Julius, the article by the Motley.Fool, summarizes most of OKO's "Irons on the Fire", <g>
fool.com
I had been waiting for the stock to start bouncing up from the $11 level,
to start buying back the shares I sold,
since it is always better to buy on the way up and to keep a trailing stop loss. <g>
But with all the bullish articles lately, I decide to started sooner,
although many people have told me
that I probably already have more than I should at my age.<g>
But I am still waiting for the stock to close above its Nov12 H of 11.43
before continuing to add more.
I always like to buy in the way up.<g>
bigcharts.marketwatch.com
Bernard
|
